Bristol Myers Squibb, the number 2 corporate patentee of cyclic-peptide technology after Bicycle, is interested in the peptides as treatments for cancer and infectious, inflammatory, and autoimmune diseases
Semaglutide is currently FDA-approved under three brand names: Ozempic for type 2 diabetes management Wegovy for chronic weight management in obesity Rybelsus an oral tablet formulation for type 2 diabetes Clinical studies have shown Semaglutide to be highly effective in reducing body weight and improving cardiometabolic health
Inflammatory Responses While rare, systemic inflammation triggered by drug reactions could contribute to musculoskeletal pain, including in the neck
PlexusDx's Precision Peptide Genetic Test ($298) analyzes 14 pathways and 150+ genetic insights related to GLP-1 response, including inflammatory and barrier-function genes that may influence skin reactivity
Recently, we highlighted two small molecule leaders in the GLP-1R agonism space, orforglipron and danuglipron